Similar articles

• Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.

  Powell JL, Kirchner AB. Powell JL, et al. J Med Assoc Ga. 1984 Jan;73(1):21-5. J Med Assoc Ga. 1984. PMID: 6707541 No abstract available.
• Pleuroperitoneal migration of intraperitoneal phosphorus-32-chromic phosphate therapy for stage I ovarian carcinoma.

  Wilkinson RH Jr. Wilkinson RH Jr. J Nucl Med. 1996 Apr;37(4):636-9. J Nucl Med. 1996. PMID: 8691256
• [Intraperitoneal irradiation in limited epithelial neoplasms of the ovary. Review of the literature].

  Wolff JP, Burini GA. Wolff JP, et al. Minerva Ginecol. 1985 Jul-Aug;37(7-8):407-13. Minerva Ginecol. 1985. PMID: 3906441 Review. Italian. No abstract available.
• Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.

  Pattillo RA, Collier BD, Abdel-Dayem H, Ozker K, Wilson C, Ruckert AC, Hamilton K. Pattillo RA, et al. J Nucl Med. 1995 Jan;36(1):29-36. J Nucl Med. 1995. PMID: 7799078
• Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications.

  Walton LA, Yadusky A, Rubinstein L. Walton LA, et al. Int J Radiat Oncol Biol Phys. 1991 May;20(5):939-44. doi: 10.1016/0360-3016(91)90189-b. Int J Radiat Oncol Biol Phys. 1991. PMID: 2022522 Review.